Stay informed about the latest developments at Wellbeing International Foundation.
Press features link to the publishing outlet. Milestone posts, science explainers, athlete updates and regulatory notes link to the full piece.
The CFT Advantage Series is now complete. All eleven papers are published and free to read from Wellbeing’s white-papers page: the fullest account yet of the science behind Cell-Free Therapy, from cellular communication and preparation through to safety, sport and healthy...
Read more →
A pilot study of Wellbeing’s multi-modal longevity protocol has been published, after peer review, in the journal Frontiers in Aging. The study is a joint piece of work by the Wellbeing team and its longevity research partner, reporting a younger measured biological age across the group after a...
Read more →
Wellbeing has closed the opening tranche of its current 2026 capital round. The round remains open at the time of publication. Specific terms, amounts, and participating investors are private and held with Wellbeing’s legal and finance team. This note is Wellbeing’s public...
Read more →
Authority Magazine, via its Medium publication, interviewed Andrew Chancellor for its long-running Five Things series on careers in health and wellness. The piece is less about the science of Wellbeing’s programme and more about the operational realities of leading a...
Read article →
Five years on from the FDA enforcement-discretion window closing, the cell-free, autologous, minimally manipulated end of regenerative-medicine research is no longer the fringe conversation it once was. The peer-reviewed publication record on extracellular vesicles and...
Read more →
Founder@, the long-form CEO interview publication, sat down with Andrew Chancellor in December 2025 for one of the more substantial conversations Wellbeing’s chief executive has given to external press. The piece runs to longer length than the November TechRound interview and...
Read article →
TechRound, the UK technology and business publication covering startups, growth-stage companies, and emerging industries, interviewed Wellbeing’s chief executive Andrew Chancellor in November 2025. The conversation was published as part of TechRound’s long-running...
Read article →
In September 2025 Wellbeing finalised a small set of agreements with athletes who had been part of the programme over a number of years and who had agreed to be quoted, named, and shown publicly. The pool now consists of five people: Jimmy Graham, Cliff Avril, Jameis Winston,...
Read more →
Science Times, the science-news publication covering research and development across multiple fields, ran a feature on Wellbeing in March 2025 focused specifically on the science behind the cell-free therapy programme and the people responsible for it. The piece is the first...
Read article →
Healthcares News, the trade publication covering healthcare strategy, innovation, and operations, ran a feature on Wellbeing focused specifically on the cell-free therapy framing and what it means as a category of intervention. The piece is shorter than the longer-form...
Read article →
The European Business Review, the UK-based publication covering business strategy, leadership and emerging industry topics, ran a feature on Wellbeing focused on the sports-recovery side of the programme. The piece is shorter than the longer-form Campden FB feature published...
Read article →
Luxurious Magazine, the UK-based lifestyle and high-end consumer publication, ran a long-form feature on Wellbeing that covered the long research arc from the 1990s Swiss laboratory work through to the current cell-free, autologous research programme. The piece is the longest...
Read article →
Campden FB, the long-standing journal covering family businesses and family offices internationally, profiled Wellbeing in a feature on its evolution, its science, and the patient relationships that have shaped it. The piece runs at the longer end of the journal’s feature...
Read article →
On May 26, 2021 the United States Food and Drug Administration closed a window that had been open since November 2017. The three-year enforcement-discretion period the agency had announced alongside its Comprehensive Regenerative Medicine Policy Framework was over. The agency...
Read more →
Wellbeing’s Q4 2020 newsletter, mailed in the closing weeks of December 2020, covered a year that asked unusual questions of every organisation operating in the clinical and research space. The newsletter was deliberately shorter than the issues that preceded it. There was...
Read more →
The pandemic year did two things to the regenerative-medicine field. It shut down patient-facing clinical operations that depended on tight, in-person logistics. And it pushed laboratories and clinicians alike to look harder at preparations that did not require living cells...
Read more →
For the first two decades of regenerative-medicine research the conversation was almost entirely about cells: which cell type to use, which source to draw it from, how to expand it in culture, how to deliver it into the body, and how to keep it alive once delivered. The shift...
Read more →
In February 2020 Wellbeing’s newsletter dedicated its main feature to the liver. The piece drew on data from the American Liver Foundation, the British Liver Trust, the Health Wellbeing’s analysis of Office for National Statistics figures, and University College London’s...
Read more →
By the autumn of 2019 Wellbeing had spent the previous two years working with a small but growing group of professional athletes, most of whom had come to the programme privately and had no interest in becoming public faces for it. The reason these voices took time to emerge...
Read more →
Newsletter Issue 2, mailed in January 2019, was Wellbeing’s second public document and the first that could meaningfully look back on a full year of activity. The 2018 calendar had been the most public year in Wellbeing’s history to that point. Issue 1 had been mailed in...
Read more →
In February 2018 Wellbeing mailed the first issue of what would become a regular, if intermittent, newsletter. The issue ran to twelve pages, was sent to a list of patients, clinicians, supporters, and research partners across the United Kingdom, the United States, and...
Read more →
Jimmy Graham, the five-time Pro Bowl tight end who has played for the New Orleans Saints, the Seattle Seahawks, the Green Bay Packers and the Chicago Bears across more than a decade in the NFL, became in early 2018 the first serving professional American football player to be...
Read more →
In November 2017 the United States Food and Drug Administration finalised a four-document Comprehensive Regenerative Medicine Policy Framework that has shaped how the autologous-biologics space operates ever since. The guidance was several years in the making. It clarified...
Read more →
If the active material of a regenerative cell therapy is not the cell itself but the cell’s secretome, the obvious next question is what, precisely, is in that secretome. A 2017 paper led by Mellows and colleagues, with Wellbeing’s Senior Consultant Scientist Dr Steve Ray...
Read more →
Through the late 2000s and early 2010s a quiet shift took place across regenerative-medicine research. Laboratories that had spent years studying how to deliver living cells to patients began noticing something inconvenient. In many of their best results, the cells themselves...
Read more →
The research lineage that became Wellbeing International Foundation began in a quiet Swiss laboratory in the early 1990s, working on a question that, at the time, very few people in regenerative medicine were asking. The accepted view was that the future of repair and...
Read more →